A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma
Clinical trial NCT01584648 · COMPLETED
Trial details
- NCT number
- NCT01584648
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-04
- Primary completion
- 2013-08-26
- Enrollment
- 423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.